To determine the specific molecular mechanism through which IL-17C activates VEGF-induced tumor angiogenesis, the expression of well-known angiogenic miRNAs was analyzed in IL-17C-treated DLD-1 cells. The gene discussed is IL17C; the disease is neoplasm.